NLRP3 and age-related macular degeneration: Thus, our findings suggest that inflammatory caspases could be important novel therapeutic targets in the comprehensive treatment or prevention of both neovascular and non‐exudative AMD, and indicate that targeting inflammatory caspases may inhibit AMD more potently than when targeting Nlrp3 or IL‐1β signaling.